RCTs deliver the most reliable evidence to guide how we treat our patients but they are badly designed, inaccurately reported and misunderstood.
We can do better.
Simon Finfer
Simon Finfer is a Pom who emigrated to Australia in 1993 to practice full time intensive care medicine. Despite being qualified 37 years and receiving a small NHS pension he still works as a bedside clinician and takes night calls. He loves his job because he works with fantastic people. He also designs and runs large clinical trials, writes papers and edits books. His current mission is to reduce the global burden of sepsis to which end he sits on the Board of the Global Sepsis Alliance, the Council of the International Sepsis Forum and established both the Australian Sepsis Network and the Asia Pacific Sepsis Alliance. He is a Professorial Fellow at The George Institute for Global Health and the Institute’s focus on equity and improving the health of underserved populations in both rich and poor countries aligns perfectly with his and with CODA. Simon lives on the outskirts of Sydney with his wife, sons, three horses, four chickens, three ducks and one dog.
Hallie Prescott
Dr. Hallie Prescott is an Assistant Professor in Pulmonary & Critical Care Medicine at the University of Michigan and staff physician at the Ann Arbor Veterans Affairs Hospital. She leads grants on post-sepsis morbidity and hospital performance measurement from the US National Institutes of Health and the US Department of Veteran’s Affairs. She is an expert in long-term outcomes and recovery after sepsis. She is a vice-chair of the Surviving Sepsis Campaign guidelines, council member of the International Sepsis Forum, and a former ANZICS Intensive Care Global Rising Star fellow (2015).
Carol Hodgson
Professor Carol Hodgson PhD FACP PT is Co-Deputy Director of the Australian and New Zealand Intensive Care Research Centre at Monash University. She has developed and led international Phase II and III trials to test early interventions to improve long-term outcomes and the quality of survival.
She leads grants (> $15M) for international, randomised trials and a binational registry.
Her work as a specialist ICU physiotherapist leading clinical research in Australia and New Zealand has led to a paradigm shift in the treatment of ICU patients, especially rehabilitation practices.
She has over 100 publications in this field and experience developing international guidelines for mechanical ventilation, early mobilisation and the management of sepsis.
